CA50091-3 - 0x0000000000006961
Males & Females of Non-Childbearing Potential
Energize
* El estipendio puede pagar hasta el monto reflejado.
Start Date:
January 17, 2026 - 2:00pm
End Date:
January 30, 2026 - 8:00am
Study Details
Study Number: CA50091
Group Number: 3
Study Requirement: Healthy Normal Male and Female
Stipend: up to $7,250.00
Study Criteria
Age: 19 - 59
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat leukemia.
Route of Administration: Oral
Blood Draws: 31
Study Schedule
Schedule Type: Long Term
Study Length: 13 Night Stay
Screening Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 1/6/2026 |
| Wednesday | 1/7/2026 |
| Monday | 1/12/2026 |
| Tuesday | 1/13/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 1/6/2026 |
| Wednesday | 1/7/2026 |
| Monday | 1/12/2026 |
| Tuesday | 1/13/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Saturday | 1/17/2026 2:00:00 PM | Friday | 1/30/2026 8:00:00 AM | 1 | Lincoln |
